Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  0.75 5.0% 15.75 173,216 08:00:00
Bid Price Offer Price High Price Low Price Open Price
15.00 16.50 15.75 15.75 15.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.03 -11.14 -4.36 39
Last Trade Time Trade Type Trade Size Trade Price Currency
16:23:55 O 2,915 15.75 GBX

Futura Medical (FUM) Latest News

More Futura Medical News
Futura Medical Investors    Futura Medical Takeover Rumours

Futura Medical (FUM) Discussions and Chat

Futura Medical Forums and Chat

Date Time Title Posts
25/11/202020:18FUTURA a winner for 20157,967
01/7/202010:05fum reality29
20/5/202010:49one million4
02/12/201613:27FUM delivering on sex,pain and rock'n'roll11,414

Add a New Thread

Futura Medical (FUM) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Futura Medical trades in real-time

Futura Medical (FUM) Top Chat Posts

Futura Medical Daily Update: Futura Medical Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 15p.
Futura Medical Plc has a 4 week average price of 13.50p and a 12 week average price of 12.25p.
The 1 year high share price is 32.50p while the 1 year low share price is currently 7.25p.
There are currently 245,626,926 shares in issue and the average daily traded volume is 348,388 shares. The market capitalisation of Futura Medical Plc is £38,686,240.85.
thebutler: Yes, some very good points raised by hawkhead. FUM cut it so fine last year because they were hoping for positive MED2005 results in December to get a far higher share price for a seemingly inevitable fund raise. So they had to pull a rabbit out of the hat otherwise they would probably have gone bust. Step forward: "...... the placebo used in the study which was Futura's proprietary transdermal DermaSys formulation also demonstrated statistically significant and clinically meaningful top line results meaning that FM57 did not meet primary endpoints versus placebo." The more you read this the louder you laugh. Rescued at the death? A cynic might suggest it's all a scam. They might be right given the woeful lack of progress throughout 2020. It will be very interesting to see if they can suck the shareholders in for another cash call this time round. DYOR.
jonnybig: Some excellent posts on LSE by hawkhead, in particular about fum probably down to their last million and only a few months cash left. Oooo could be a heavily discounted placing on the horizon permanently down rating the share price and wiping out lots of shareholders who bought in much higher!
glavey: Yes and such a fabulous update from the company. Fantastic news in abundance. Given the market wide rise on Friday I can't understand why FUM share price didn't build on Thursday's gains. But the retrace presents a great buying opportunity. It's amazing that so many are obviously missing out here.
thebutler: Yes very much a non RNS. In fact very desperate. Why update the Market before they've received the FDA minutes? And looks like the study results will not be available until well into 2022. And "still under review" in the EU. Why shouldn't it be? Furthermore they are now "claiming" to be close to closing a deal (yeah, jim, we've heard it all before lol!) but I thought the recent highly dilutive placings were FUM wanting to go it alone as it locked more value into a commercially approved product? Clear as mud? That's FUM! But what had me roaring with laughter was Barder's comment at the end: "We are increasingly excited ............." Lol, you've been excited for the past 17 years now, Jim. Excited at drawing your huge salary for doing nak all? Yeah, that must be it! Back to the share price A very weak "rally" hitting that 16p yet again and falling off. Still panning out exactly as I said it would, back to the crucial 14p very soon.
petroc: Thanks, jonnybutler! Just when the share price needed a bit of a helping hand, up you pop and magically it rises! You know, if it ever did play out exactly as you predicted time after time, the share price would be in minus figures and FUM would have gone bust by now! That's spooky! Anyway, thanks again for your timely intervention.
thebutler: Hi jonny, hope you're keeping well. Got a great idea how to get round the 10pm pub curfew. Off out an hour earlier. Our little secret, eh? Back to FUM. I don't think these clowns have anything left in the tank to ramp up the share price The previous couple of years (before the placings) there was of course the impending MED results which Lombard were able to sell into. No such luck for them this year. So when will they start offloading? Q2 2021 FUM estimate their remaining cash reserves so they'll probably need to raise funds a quarter in advance, so I reckon the time is almost upon us. This continues to play out exactly how I said it would. Just managed to stay above the 12p I mentioned so closed the gap to 17p but just look at that chart now. LOOK AT IT! Well and truly broken below 15p so 12p will be tested very very soon and if it breaks this time it's blood bath time. The very best of luck to everyone but always remember to DYOR.
loobrush: from LSE What next? More cash or just a huge share price rise.Today 12:28 What can be expected next. Clearly they will need cash to do the US trial that the FDA have requested, but do they need it now. My opinion is that they will wait to get the EU approval due out in the next few months first. When they get this the share price will rocket and they will get a deal with one of the Pharma companies for Europe. This deal will probably include the Pharma paying for the US trial with rights to the US market as well if the US trial goes ok . So possibly no more fund raising would be required in this case. In fact with the EU results being not that far way someone could come in at any time to scoop up a deal with FUM at any time. Could be next week or next month-but at todays price the rise could be as much as one of the vavoured covid stocks. Lets see. I'm now in with a 100,000 plus shares and betting ona big win here.
petroc: Share price when jonnybutler said "let the fall recommence" - 16p. Share price when jonnybutler congratulated himself on his good call - 16p.
glavey: "Yes a P_l_a_c_e_b_o that is going to make lots of money for the shareholders" That's dependent on two things, speculators timing pump and dump on the share price (a zero sum game), FUM somehow getting a product to market with sufficient marketing push behind it to convince enough consumers influenced by the hype to buy in to an over the counter product which provides an admission that they suffer from erectile disfunction. Then getting repeat purchases. That's assuming they can get the clinical approvals and someone to take it on. "They used it as a zero dose version in the trials instead of a true placebo..." No, that is and was the placebo! What you are now being asked to swallow is that both samples with and without the active ingredient 'proved' to have a useful effect in a 3rd stage trial. But within that hypothesis there was no 'control'. Similarly the 'magical' effect passed through first and second stage trials without being noticed. " is totally incorrect to call their product a placebo..." Even FUM call it a placebo: "...the last set of results as far as we've seen them were outstanding..." Yes, incomplete, unresolved, and leaving a lot of questions outstanding.
glavey: BTW Tinman, I'm sorry I forgot to answer this for you: "it’s time for you to admit that you’ve been wrong aswell. No point now trying to back track on your comments. You got it wrong" Why don't you have a look back and you will see that I expressed doubt over FUM as an investment when the share price was being 'promoted' to above 40p into the summer of 2019. The share price sunk as 'promotors' took profit and crashed when the trials failed and the money had run out. A dilutive fundraise followed. I think any reasonable person summing that up would be more likely to think 'you got it right' rather than 'you got it wrong'. That said I ordinarily don't feel it necessary to defend my views - I'm happy to let the overall market determine that. Going forward things to be considered now are a) why it took until the trial failure (co-inciding with a need for additional funding) for FUM to 'discover' the placibo gel has 'magical' effects, b) why they suggest it is used in conjunction with other proven, readily available medications when it had previously been argued MED whatever should replace them, c) why one large stockholder, post trial failure, desired not only to absorb a significant placing but also underwrite a retail offering, d) why the share price did not fall in Feb/Mar at a time when just about all other stocks did, e) why it is rising now. Finally, why did Blue Diamond fail to sell if it contained the magic ingredient?
Futura Medical share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201125 22:46:12